Year |
Citation |
Score |
2015 |
Sheriff J, Tran PL, Hutchinson M, DeCook T, Slepian MJ, Bluestein D, Jesty J. The platelet hammer: In vitro platelet activation under repetitive hypershear. Conference Proceedings : ... Annual International Conference of the Ieee Engineering in Medicine and Biology Society. Ieee Engineering in Medicine and Biology Society. Annual Conference. 2015: 262-5. PMID 26736250 DOI: 10.1109/EMBC.2015.7318350 |
0.333 |
|
2015 |
Sheriff J, Tran PL, Hutchinson M, DeCook T, Slepian MJ, Bluestein D, Jesty J. Repetitive Hypershear Activates and Sensitizes Platelets in a Dose-Dependent Manner. Artificial Organs. PMID 26527361 DOI: 10.1111/Aor.12602 |
0.427 |
|
2014 |
Sheriff J, Girdhar G, Chiu WC, Jesty J, Slepian MJ, Bluestein D. Comparative efficacy of in vitro and in vivo metabolized aspirin in the DeBakey ventricular assist device. Journal of Thrombosis and Thrombolysis. 37: 499-506. PMID 24043375 DOI: 10.1007/S11239-013-0997-6 |
0.415 |
|
2013 |
Sheriff J, Soares JS, Xenos M, Jesty J, Slepian MJ, Bluestein D. Evaluation of shear-induced platelet activation models under constant and dynamic shear stress loading conditions relevant to devices. Annals of Biomedical Engineering. 41: 1279-96. PMID 23400312 DOI: 10.1007/S10439-013-0758-X |
0.374 |
|
2013 |
Sheriff J, Soares JS, Xenos M, Jesty J, Slepian MJ, Bluestein D. Erratum to: Evaluation of Shear-Induced Platelet Activation Models Under Constant and Dynamic Shear Stress Loading Conditions Relevant to Devices Annals of Biomedical Engineering. 41: 2712-2712. DOI: 10.1007/S10439-013-0927-Y |
0.372 |
|
2012 |
Girdhar G, Xenos M, Alemu Y, Chiu WC, Lynch BE, Jesty J, Einav S, Slepian MJ, Bluestein D. Device thrombogenicity emulation: a novel method for optimizing mechanical circulatory support device thromboresistance. Plos One. 7: e32463. PMID 22396768 DOI: 10.1371/Journal.Pone.0032463 |
0.34 |
|
2011 |
Claiborne TE, Girdhar G, Gallocher-Lowe S, Sheriff J, Kato YP, Pinchuk L, Schoephoerster RT, Jesty J, Bluestein D. Thrombogenic potential of Innovia polymer valves versus Carpentier-Edwards Perimount Magna aortic bioprosthetic valves. Asaio Journal (American Society For Artificial Internal Organs : 1992). 57: 26-31. PMID 20930618 DOI: 10.1097/Mat.0B013E3181Fcbd86 |
0.311 |
|
2010 |
Alemu Y, Girdhar G, Xenos M, Sheriff J, Jesty J, Einav S, Bluestein D. Design optimization of a mechanical heart valve for reducing valve thrombogenicity-A case study with ATS valve. Asaio Journal (American Society For Artificial Internal Organs : 1992). 56: 389-96. PMID 20613492 DOI: 10.1097/Mat.0B013E3181E65Bf9 |
0.325 |
|
2010 |
Xenos M, Girdhar G, Alemu Y, Jesty J, Slepian M, Einav S, Bluestein D. Device Thrombogenicity Emulator (DTE)--design optimization methodology for cardiovascular devices: a study in two bileaflet MHV designs. Journal of Biomechanics. 43: 2400-9. PMID 20483411 DOI: 10.1016/J.Jbiomech.2010.04.020 |
0.362 |
|
2010 |
Sheriff J, Bluestein D, Girdhar G, Jesty J. High-shear stress sensitizes platelets to subsequent low-shear conditions. Annals of Biomedical Engineering. 38: 1442-50. PMID 20135353 DOI: 10.1007/S10439-010-9936-2 |
0.411 |
|
2009 |
Jesty J, Wieland M, Niemiec J. Assessment in vitro of the active hemostatic properties of wound dressings. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. 89: 536-42. PMID 18985792 DOI: 10.1002/Jbm.B.31245 |
0.424 |
|
2008 |
Damon AL, Scudder LE, Gnatenko DV, Sitaraman V, Hearing P, Jesty J, Bahou WF. Altered bioavailability of platelet-derived factor VIII during thrombocytosis reverses phenotypic efficacy in haemophilic mice. Thrombosis and Haemostasis. 100: 1111-22. PMID 19132238 DOI: 10.1160/Th08-04-0242 |
0.434 |
|
2008 |
Girdhar G, Xu S, Jesty J, Bluestein D. In vitro model of platelet-endothelial activation due to cigarette smoke under cardiovascular circulation conditions. Annals of Biomedical Engineering. 36: 1142-51. PMID 18452059 DOI: 10.1007/S10439-008-9503-2 |
0.412 |
|
2007 |
Damon AL, Jesty J, Scudder LE, Gnatenko DV, Bahou WF. Megakaryocyte/Platelet-Restricted FVIII Expression Using a Platelet Factor 4 Promoter: Determination of Activation State and In Vivo Efficacy during Thrombocytosis. Blood. 110: 1142-1142. DOI: 10.1182/Blood.V110.11.1142.1142 |
0.431 |
|
2006 |
Perdekamp MT, Rubenstein DA, Jesty J, Hultin MB. Platelet factor V supports hemostasis in a patient with an acquired factor V inhibitor, as shown by prothrombinase and tenase assays. Blood Coagulation & Fibrinolysis : An International Journal in Haemostasis and Thrombosis. 17: 593-7. PMID 16988558 DOI: 10.1097/01.Mbc.0000245297.64644.Ee |
0.464 |
|
2006 |
Ghebrehiwet B, CebadaMora C, Tantral L, Jesty J, Peerschke EI. gC1qR/p33 serves as a molecular bridge between the complement and contact activation systems and is an important catalyst in inflammation. Advances in Experimental Medicine and Biology. 586: 95-105. PMID 16893067 DOI: 10.1007/0-387-34134-X_7 |
0.374 |
|
2006 |
Bluestein D, Einav S, Titmus M, Dumont K, Alemu Y, Ghebrehiwet B, Jesty J, Okser S, Deng Y. Platelet activity measurements and numerical simulations of flow induced thrombus formation in cardiovascular pathologies and devices Journal of Biomechanics. 39: S256. DOI: 10.1016/S0021-9290(06)83974-6 |
0.378 |
|
2005 |
Schulz-Heik K, Ramachandran J, Bluestein D, Jesty J. The extent of platelet activation under shear depends on platelet count: differential expression of anionic phospholipid and factor Va. Pathophysiology of Haemostasis and Thrombosis. 34: 255-62. PMID 16772736 DOI: 10.1159/000093104 |
0.464 |
|
2005 |
Yin W, Gallocher S, Pinchuk L, Schoephoerster RT, Jesty J, Bluestein D. Flow-induced platelet activation in a St. Jude mechanical heart valve, a trileaflet polymeric heart valve, and a St. Jude tissue valve. Artificial Organs. 29: 826-31. PMID 16185345 DOI: 10.1111/J.1525-1594.2005.29109.X |
0.337 |
|
2005 |
Bluestein D, Yin W, Alemu Y, Zhou M, Ladeinde F, Schoephoerster R, Jesty J. Flow induced platelet activation in prosthetic heart valves - In vitro and numerical studies Proceedings of the 2005 Summer Bioengineering Conference. 2005: 1082-1083. |
0.304 |
|
2004 |
Ramachandran J, Rubenstein D, Bluestein D, Jesty J. Activation of platelets exposed to shear stress in the presence of smoke extracts of low-nicotine and zero-nicotine cigarettes: the protective effect of nicotine. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 6: 835-41. PMID 15700919 DOI: 10.1080/1462220042000274284 |
0.315 |
|
2004 |
Yin W, Alemu Y, Affeld K, Jesty J, Bluestein D. Flow-induced platelet activation in bileaflet and monoleaflet mechanical heart valves. Annals of Biomedical Engineering. 32: 1058-66. PMID 15446502 DOI: 10.1114/B:Abme.0000036642.21895.3F |
0.397 |
|
2004 |
Bluestein D, Yin W, Affeld K, Jesty J. Flow-induced platelet activation in mechanical heart valves. The Journal of Heart Valve Disease. 13: 501-8. PMID 15222299 |
0.323 |
|
2004 |
Bahou WF, Scudder L, Rubenstein D, Jesty J. A shear-restricted pathway of platelet procoagulant activity is regulated by IQGAP1. The Journal of Biological Chemistry. 279: 22571-7. PMID 15026422 DOI: 10.1074/Jbc.M402561200 |
0.428 |
|
2004 |
Rubenstein D, Jesty J, Bluestein D. Differences between mainstream and sidestream cigarette smoke extracts and nicotine in the activation of platelets under static and flow conditions. Circulation. 109: 78-83. PMID 14691035 DOI: 10.1161/01.Cir.0000108395.12766.25 |
0.365 |
|
2004 |
Yin W, Jesty J, Alemu Y, Bluestein D. Effects of valve design and orientation on flow induced platelet activation in mechanical heart valves Advances in Bioengineering, Bed. 37-38. |
0.314 |
|
2003 |
Jesty J, Yin W, Perrotta P, Bluestein D. Platelet activation in a circulating flow loop: combined effects of shear stress and exposure time. Platelets. 14: 143-9. PMID 12850838 DOI: 10.1080/0953710031000092839 |
0.424 |
|
2002 |
Bluestein D, Yin W, Alemu Y, Jesty J, Saltman AE, Krukenkamp IB, Bernal O, Suresh K. Platelet activation and free emboli formation in flow past mechanical heart valves numerical and in vivo studies Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 2: 1250-1251. DOI: 10.1115/IMECE2002-32288 |
0.313 |
|
2002 |
Bluestein D, Yin W, Alemu Y, Jesty J, Saltman AE, Krukenkamp IB, Bernal O, Suresh K. Platelet activation and free emboli formation in flow past mechanical heart valves numerical and in vivo studies Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 2: 1250-1251. |
0.313 |
|
2002 |
Yin W, Bluestein D, Jesty J, Perrotta P. Flow induced platelet activation in mechanical heart valves - in vitro studies Annual International Conference of the Ieee Engineering in Medicine and Biology - Proceedings. 2: 1599-1600. |
0.316 |
|
2001 |
Bluestein D, Jesty J, Saltman AE, Krukenkamp IB, Suresh K. Platelet activation in flow past mechanical heart valves American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 51: 221-222. |
0.32 |
|
2001 |
Bluestein D, Yun YH, Krukenkamp IB, Jesty J. Flow induced platelet activation in mechanical heart valves - Numerical and in vitro studies American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 50: 651-652. |
0.316 |
|
2000 |
Raz S, Grad Y, Einav S, Jesty J, Bluestein D. Flow induced platelet activation in models of blood recirculating devices Asaio Journal. 46: 186. DOI: 10.1097/00002480-200003000-00141 |
0.384 |
|
1999 |
Jesty J, Bluestein D. Acetylated prothrombin as a substrate in the measurement of the procoagulant activity of platelets: Elimination of the feedback activation of platelets by thrombin Analytical Biochemistry. 272: 64-70. PMID 10405294 DOI: 10.1006/Abio.1999.4148 |
0.462 |
|
1999 |
Bluestein D, Siddiqui A, Jesty J. Measurement of the flow induced procoagulant properties of platelets in a mechanical heart valve using prothrombin acetylation American Society of Mechanical Engineers, Bioengineering Division (Publication) Bed. 42: 567-568. |
0.307 |
|
1998 |
Peerschke EIB, Jesty J, Reid KBM, Ghebrehiwet B. The soluble recombinant form of a binding protein/receptor for the globular domain of C1q (gC1qR) enhances blood coagulation Blood Coagulation and Fibrinolysis. 9: 29-37. PMID 9607116 DOI: 10.1097/00001721-199801000-00004 |
0.396 |
|
1998 |
Zucker S, Mirza H, Conner CE, Lorenz AF, Drews MH, Bahou WF, Jesty J. Vascular endothelial growth factor induces tissue factor and matrix metalloproteinase production in endothelial cells: Conversion of prothrombin to thrombin results in progelatinase A activation and cell proliferation International Journal of Cancer. 75: 780-786. PMID 9495249 DOI: 10.1002/(Sici)1097-0215(19980302)75:5<780::Aid-Ijc19>3.0.Co;2-A |
0.314 |
|
1996 |
Jesty J, Lorenz A, Rodriguez J, Wun TC. Initiation of the tissue factor pathway of coagulation in the presence of heparin: Control by antithrombin III and tissue factor pathway inhibitor Blood. 87: 2301-2307. PMID 8630391 DOI: 10.1182/Blood.V87.6.2301.Bloodjournal8762301 |
0.405 |
|
1994 |
Jesty J. Kinetics of the inhibition of factor Xa and the tissue factor-factor viia complex by the tissue factor pathway inhibitor in the presence and absence of heparin Biochemistry®. 33: 12686-12694. PMID 7918495 DOI: 10.1021/Bi00208A020 |
0.344 |
|
1992 |
Neuenschwander PF, Jesty J. Thrombin-activated and factor Xa-activated human factor VIII: differences in cofactor activity and decay rate. Archives of Biochemistry and Biophysics. 296: 426-34. PMID 1632634 DOI: 10.1016/0003-9861(92)90593-L |
0.389 |
|
1991 |
Jesty J. Interaction of feedback control and product inhibition in the activation of factor X by factors IXa and VIII Haemostasis. 21: 208-218. PMID 1794747 DOI: 10.1159/000216230 |
0.372 |
|
1990 |
Neuenschwander P, Jesty J. The use of acetylated factor X to prevent feedback activation of factor VIII during factor X activation: a tool for kinetic studies. Analytical Biochemistry. 184: 347-52. PMID 2109550 DOI: 10.1016/0003-2697(90)90692-3 |
0.395 |
|
1988 |
Neuenschwander P, Jesty J. A comparison of phospholipid and platelets in the activation of human factor VIII by thrombin and factor Xa, and in the activation of factor X. Blood. 72: 1761-70. PMID 3140913 DOI: 10.1182/Blood.V72.5.1761.1761 |
0.44 |
|
1986 |
Morrison SA, Lidonnici K, Jesty J. Effect of limited modification of amino groups on the reactivity of human factor Xa Bba - General Subjects. 884: 409-418. PMID 3778932 DOI: 10.1016/0304-4165(86)90191-1 |
0.335 |
|
1986 |
Jesty J. Measurement of the kinetics of inhibition of activated coagulation factor X in human plasma: The effect of plasma and inhibitor concentration Analytical Biochemistry. 152: 402-411. PMID 2421604 DOI: 10.1016/0003-2697(86)90427-6 |
0.35 |
|
1985 |
Jesty J. The kinetics of inhibition of thrombin by antithrombin in the presence of components of the hemostatic system Blood. 66: 1189-1195. PMID 4052633 DOI: 10.1182/Blood.V66.5.1189.Bloodjournal6651189 |
0.378 |
|
1985 |
Miller BC, Hultin MB, Jesty J. Altered factor VII activity in hemophilia Blood. 65: 845-849. PMID 3978230 DOI: 10.1182/Blood.V65.4.845.Bloodjournal654845 |
0.387 |
|
1984 |
Jesty J, Morrison SA, Harpel PC. Measurement of human activated Factor X-antithrombin complex by an enzyme-linked differential-antibody immunosorbent assay Analytical Biochemistry. 139: 158-167. PMID 6742427 DOI: 10.1016/0003-2697(84)90401-9 |
0.371 |
|
1984 |
Morrison SA, Jesty J. Tissue factor-dependent activation of tritium-labeled factor IX and factor X in human plasma Blood. 63: 1338-1347. PMID 6722352 |
0.307 |
|
1983 |
Jesty J, Morrison SA. The activation of factor IX by tissue factor-factor VII in a bovine plasma system lacking factor X Thrombosis Research. 32: 171-181. PMID 6658712 DOI: 10.1016/0049-3848(83)90028-2 |
0.392 |
|
1981 |
Hultin MB, Jesty J. The activation and inactivation of human factor VIII by thrombin: Effect of inhibitors of thrombin Blood. 57: 476-482. PMID 6779877 |
0.311 |
|
1978 |
Jesty J. The inhibition of activated bovine coagulation factors X and VII by antithrombin III Archives of Biochemistry and Biophysics. 185: 165-173. PMID 564164 DOI: 10.1016/0003-9861(78)90156-X |
0.37 |
|
1976 |
Jesty J, Nemerson Y. [11] The activation of bovine coagulation factor X Methods in Enzymology. 45: 95-107. PMID 1012042 DOI: 10.1016/S0076-6879(76)45014-0 |
0.372 |
|
Show low-probability matches. |